Name | Title | Contact Details |
---|---|---|
Pavan Battiprolu |
Senior Director - Translational Research, Clinical Operations & Alliance Management | Profile |
Christopher Herzog |
Senior Director, Nonclinical R&D | Profile |
Christopher Herzog |
Associate Vice President, AAV Research and Development | Profile |
Isabel Carmona |
Senior Vice President and Chief Human Resources Officer | Profile |
Founded in 2019, Totus Medicines uses revolutionary chemical biology to create life-changing therapies to treat previously untreatable diseases across the entire human genome. Totus is based in Cambridge, Massachusetts.
Enthrive is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Using our proprietary platform technology, GT Biopharma is generating novel immuno-oncology biopharmaceutical drugs targeting cancers such as acute lymphocytic leukemia, non-Hodgkin`s lymphoma, acute myeloid leukemia and multiple solid tumors by leveraging our proprietary NK cell engager (TriKE™) platform technology.
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. The company was founded on breakthrough computationally-designed virus like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington. Icosavax is located in Seattle.
Anichem is a North Brunswick, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.